Schonfeld Strategic Advisors’s Korro Bio KRRO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-90,186	Closed	-$4.32M	–	2324
2025 Q3	$4.32M	Buy	+90,186	New	+$2M	0.02%	654
2025 Q2	–	Sell	-30,475	Closed	-$531K	–	2301
2025 Q1	$531K	Sell	30,475 -82,590	-73%	-$2.45M	﹤0.01%	1561
2024 Q4	$4.3M	Sell	113,065 -29,580	-21%	-$1.52M	0.03%	550
2024 Q3	$4.77M	Buy	142,645 +102,342	+254%	+$4.31M	0.03%	561
2024 Q2	$1.37M	Buy	+40,303	New	+$2.23M	0.01%	1069
2022 Q2	–	Sell	-620	Closed	-$66K	–	2775
2022 Q1	$66K	Buy	+620	New	+$118K	﹤0.01%	2300
2021 Q2	–	Sell	-400	Closed	-$190K	–	2128
2021 Q1	$190K	Buy	+400	New	+$777K	﹤0.01%	1532

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Schonfeld Strategic Advisors's KRRO Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Korro Bio (KRRO) in Q4 2025, closing a stake of 90,186 shares — an estimated $4.32M sold.

Schonfeld Strategic Advisors first reported a position in KRRO in Q1 2021 and held it in 7 quarters. The position peaked at $4.77M in Q3 2024. 83 funds tracked by Wall St. Rank hold KRRO as of Q4 2025.

Schonfeld Strategic Advisors reported no remaining Korro Bio position as of Q4 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 90,186 Korro Bio shares in Q4 2025, an estimated $4.32M.
Schonfeld Strategic Advisors first reported a position in Korro Bio in Q1 2021 and held it in 7 quarters.
Schonfeld Strategic Advisors's Korro Bio position peaked at $4.77M in Q3 2024.
83 funds tracked by Wall St. Rank held Korro Bio as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.